Ocugen Investor (@kickstarterx10) header
Ocugen Investor (@kickstarterx10) profile picture

Investor & holder of Ocugen. Ocugen 2032 Revenue forecast for real? (40B+ by 2032 from OCU400/OCU410 revenues)

Not Investment advice
Joined April 2022
$OCGN @drsmusunuri Please hear your shareholders.
🤖 Made with AI
1
1
16
2,624
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
5
289
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
3
4
392
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
6
349
$OCGN Vote NO! @drsmusunuri STEP DOWN!
Replying to @NattaCop
The vote will fail in December, just the same as it failed in October. Nothing has changed. The vote failing, is the most bullish thing that could happen. The shorts have been front running expected dilution. Take the dilution away, and they have to cover. ...
5
285
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
6
255
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
4
220
$OCGN At 50 centers treating 5 patients/day each, 100K patients could be treated in 1.5 years, NOT 8! OCU400 has huge potential, but execution matters. Secure a strong U.S. partner, deliver a credible commercial plan, STOP further dilution. VOTE NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
7
471
$OCGN Vote NO! @drsmusunuri STEP DOWN!
🤖 Made with AI
1
7
272
$OCGN Vote NO! @drsmusunuri STEP DOWN!
Ocugen CEO @drsmusunuri joined @BBC Correspondent @JamesTGallagher at Cell & Gene Leaders Live to discuss our modifier gene therapy platform and its potential to address vision loss across a broader patient population. #GeneTherapy #Biotech $OCGN
1
6
432
$OCGN Japan Airlines’ Nishimatsu cut his own pay in tough times. @drsmusunuri & Board lead by example. Reduce salary, suspend cash bonuses, cap equity awards and tie rewards to delivery. Protect shareholder capital. STEP UP or STEP DOWN.
🤖 Made with AI
1
10
565